Emeline Tabouret

22PUBLICATIONS
124CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedMolecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 09, 2026
Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Cameron Crowell, Nikhil P Mankuzhy, Julie Bennett

|Oct 16, 2025
Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. Cancers 2020, 12, 1935.

Emeline Tabouret, Herui Wang, Niranjana Amin

|Nov 22, 2024
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection.

Felix Sahm, Luca Bertero, Sebastian Brandner

|Oct 21, 2024
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort.

Domique Figarella-Branger, Carole Colin, Karima Mokhtari

|Oct 02, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Salah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret

|Sep 10, 2024
Brain tumoroids: Treatment prediction and drug development for brain tumors with fast, reproducible, and easy-to-use personalized models.

Aurélie Soubéran, Carine Jiguet-Jiglaire, Soline Toutain

Pageof 4

Frequent Collaborators

7 joint publications

Domique Figarella-Branger

3 joint publications

Ahmed Idbaïh

2 joint publications

Niranjana Amin

2 joint publications

Georges Noel